Expert Opinion on Emerging Drugs

Emerging adenosine receptor agonists - an update
pp. 597-602(6)
Authors: Gao, Zhan-Guo; Jacobson, Kenneth A

Emerging pharmacotherapy of tinnitus
pp. 603-606(4)
Authors: Langguth, Berthold; Elgoyhen, Ana Belén

Emerging GLP-1 receptor agonists
pp. 607-618(12)
Authors: Lund, Asger; Knop, Filip K; Vilsbøll, Tina

Emerging drugs which target the renin-angiotensin-aldosterone system
pp. 619-630(12)
Authors: Steckelings, Ulrike Muscha; Paulis, Ludovit; Unger, Thomas; Bader, Michael

Emerging drugs for panic disorder
pp. 631-645(15)
Authors: Perna, Giampaolo; Guerriero, Giuseppe; Caldirola, Daniela

Emerging drugs in metastatic breast cancer: an update
pp. 647-667(21)
Authors: Arslan, Cagatay; Altundag, Kadri; Dizdar, Omer

Emerging drugs for diabetic retinopathy
pp. 669-681(13)
Authors: Pipis, Antonios; Scholl, Stefan; Augustin, Albert J

Emerging drugs for the treatment of transplant rejection
pp. 683-695(13)
Authors: Kihm, Lars P; Zeier, Martin; Morath, Christian

Emerging oral drugs for relapsing-remitting multiple sclerosis
pp. 697-712(16)
Authors: Gasperini, Claudio; Ruggieri, Serena

Emerging pipeline drugs for hepatitis B infection
pp. 713-729(17)
Authors: Cox, Natravis; Tillmann, Hans

Erratum
pp. 731-731(1)